{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:28:55Z","timestamp":1789003735168,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CONICYT\/FONDECYT","award":["3140455"],"award-info":[{"award-number":["3140455"]}]},{"name":"POSTDOCTORADO","award":["3160249"],"award-info":[{"award-number":["3160249"]}]},{"name":"DOCTORADO"},{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","award":["21130507"],"award-info":[{"award-number":["21130507"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["1070352"],"award-info":[{"award-number":["1070352"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"FONDEF","doi-asserted-by":"crossref","award":["D061008"],"award-info":[{"award-number":["D061008"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008736","name":"FONDEF","doi-asserted-by":"crossref","award":["D11I1080"],"award-info":[{"award-number":["D11I1080"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013928","name":"Millennium Institute on Immunology and Immunotherapy","doi-asserted-by":"crossref","award":["P09\/016-F"],"award-info":[{"award-number":["P09\/016-F"]}],"id":[{"id":"10.13039\/501100013928","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2016.12.048","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T06:00:15Z","timestamp":1483682415000},"page":"757-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Pablo F.","family":"C\u00e9spedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rey-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janyra A.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Canedo-Marroqu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2016.12.048_b0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197903083001004","article-title":"Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children","volume":"300","author":"Henderson","year":"1979","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.048_b0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/524019","article-title":"Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya","volume":"46","author":"Nokes","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9725","key":"10.1016\/j.vaccine.2016.12.048_b0015","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-0031-1283282","article-title":"Respiratory syncytial virus infection in adults","volume":"32","author":"Walsh","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.vaccine.2016.12.048_b0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/aje\/kws257","article-title":"The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease","volume":"176","author":"Ohuma","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.048_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3111\/13696990903583404","article-title":"Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life","volume":"13","author":"Forbes","year":"2010","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.048_b0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1155\/2013\/916769","article-title":"A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals","volume":"24","author":"Jacobs","year":"2013","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.048_b0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.33321\/cdi.2011.35.15","article-title":"Respiratory syncytial virus\u2013the unrecognised cause of health and economic burden among young children in Australia","volume":"35","author":"Ranmuthugala","year":"2011","journal-title":"Commun Dis Intell Q Rep"},{"issue":"1 Pt A","key":"10.1016\/j.vaccine.2016.12.048_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.imlet.2014.09.006","article-title":"Respiratory syncytial virus: pathology, therapeutic drugs and prophylaxis","volume":"162","author":"Gomez","year":"2014","journal-title":"Immunol Lett"},{"issue":"7467","key":"10.1016\/j.vaccine.2016.12.048_b0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature12442","article-title":"Cross-neutralization of four paramyxoviruses by a human monoclonal antibody","volume":"501","author":"Corti","year":"2013","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.048_b0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1164\/rccm.201002-0221OC","article-title":"Viral load drives disease in humans experimentally infected with respiratory syncytial virus","volume":"182","author":"DeVincenzo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"52","key":"10.1016\/j.vaccine.2016.12.048_b0060","doi-asserted-by":"crossref","first-page":"20822","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.048_b0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2249.2007.03497.x","article-title":"Differential response of human naive and memory\/effector T cells to dendritic cells infected by respiratory syncytial virus","volume":"150","author":"Rothoeft","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2016.12.048_b0070","doi-asserted-by":"crossref","first-page":"E3214","DOI":"10.1073\/pnas.1400760111","article-title":"Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells","volume":"111","author":"Cespedes","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.048_b0075","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.048_b0080","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/512615","article-title":"Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses","volume":"195","author":"Welliver","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.048_b0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/adc.71.5.428","article-title":"Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection","volume":"71","author":"Everard","year":"1994","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.048_b0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/modpathol.3800725","article-title":"The histopathology of fatal untreated human respiratory syncytial virus infection","volume":"20","author":"Johnson","year":"2007","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.048_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1843.2000.00219.x","article-title":"The interaction of neutrophils with respiratory epithelial cells in viral infection","volume":"5","author":"Wang","year":"2000","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.048_b0100","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1164\/ajrccm.159.6.9805083","article-title":"Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation","volume":"159","author":"Harrison","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.048_b0105","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.0802262","article-title":"Subversion of pulmonary dendritic cell function by paramyxovirus infections","volume":"182","author":"Guerrero-Plata","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2016.12.048_b0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"39","author":"Castilow","year":"2007","journal-title":"Immunol Res"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.048_b0125","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/eji.201344206","article-title":"Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease","volume":"44","author":"Srinivasa","year":"2014","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.048_b0130","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.4049\/jimmunol.181.11.7958","article-title":"The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia","volume":"181","author":"Olson","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/vim.2009.0016","article-title":"Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease","volume":"22","author":"Stevens","year":"2009","journal-title":"Viral Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.12.048_b0140","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.4049\/jimmunol.0903452","article-title":"Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guerin promotes virus clearance and protects from infection","volume":"185","author":"Cautivo","year":"2010","journal-title":"J Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2016.12.048_b0145","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1073\/pnas.1217508110","article-title":"Impaired learning resulting from respiratory syncytial virus infection","volume":"110","author":"Espinoza","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2016.12.048_b0150","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1099\/vir.0.015396-0","article-title":"Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus","volume":"91","author":"Herd","year":"2010","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.048_b0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/rmv.1813","article-title":"Central nervous system alterations caused by infection with the human respiratory syncytial virus","volume":"24","author":"Bohmwald","year":"2014","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2016.12.048_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.08.033","article-title":"Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: Why does BCG fail to protect against tuberculosis?","author":"Moliva","year":"2015","journal-title":"Vaccine"},{"issue":"9517","key":"10.1016\/j.vaccine.2016.12.048_b0165","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.048_b0170","first-page":"635","article-title":"Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity","volume":"32","author":"Aggarwal","year":"1995","journal-title":"Indian Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0175","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1165\/rcmb.2013-0414OC","article-title":"Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection","volume":"51","author":"Kolli","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/rcmb.2007-0224RC","article-title":"The prolonged life-span of alveolar macrophages","volume":"38","author":"Murphy","year":"2008","journal-title":"Am J Respir Cell Mol Biol."},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.048_b0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.187.4.561","article-title":"Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia","volume":"187","author":"Erb","year":"1998","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2016.12.048_b0190","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.048_b0195","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/intimm\/dxn094","article-title":"Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells","volume":"20","author":"Yokoi","year":"2008","journal-title":"Int Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.048_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.08.033","article-title":"Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand","volume":"130","author":"Han","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.048_b0205","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2012.07.031","article-title":"Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection","volume":"130","author":"Lee","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.12.048_b0210","first-page":"53","article-title":"Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells","volume":"6","author":"Miazgowicz","year":"2013","journal-title":"J Inflamm Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:10:54Z","timestamp":1749852654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X16312737"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}